Skip to content

Patients › Hand

Knuckle Joint Replacement (MCPJ)

PDF In-depth PDF Evidence
Updated Aug 20264 citations

Why this operation has been suggested

Dr Kieran Hirpara, an upper-limb surgeon at Mater Private Hospital Rockhampton, starts with the least invasive options that suit your condition. Patients are generally referred to our clinic by their GP; if a physiotherapist has suggested you see us, you will still need a referral from your GP in order to be eligible for the Medicare rebate. A clinic assessment establishes the diagnosis. For degenerative or long-standing problems we usually try non-operative care — activity change, physiotherapy or hand therapy, splinting, and injections — and consider surgery when that has not given enough improvement. For structural or acute problems, surgery may be recommended straight away.

We offer this procedure to relieve pain and improve function in your knuckle joint. It is typically recommended for wear-and-tear arthritis, non-inflammatory arthritis, or rheumatoid arthritis that affects the joint. It may also be used for complex trauma or deformity. The main benefit is predictable pain relief and improved hand appearance. While some patients may need a revision procedure at 5 years, the operation aims to restore stability and ease daily tasks.

Before the operation

Please fast for seven hours before your surgery. We ask for this extra time so your operation can start earlier if the list runs ahead. You must arrange a lift home and wear comfortable clothing. Bring a list of all your current medications to help your surgeon plan safely. We will review X-rays or other scans to prepare for your procedure. If you have other medical conditions, you may need blood tests or a review with the anaesthetist. Otherwise, these are not routine. Your surgeon will give you specific instructions on which medications to stop. Please follow their guidance closely to ensure your safety and comfort on the day of your operation.

On the day

You present to the hospital's surgical admissions unit. Here you are checked in and prepared for theatre. You meet the anaesthetist to discuss your care. This operation is done under general anaesthetic. A regional nerve block is sometimes added for post-operative pain relief — the anaesthetist will discuss this with you on the day.

You are then taken into the operating theatre, where the operation is performed. You wake up in the recovery area, where nurses monitor you while the anaesthetic wears off. Once you are stable you either go to the ward or go home, depending on the procedure and your recovery.

What the operation involves

Your surgeon makes a cut over the back of your knuckle to access the joint. The worn-out surfaces of your bone are removed. This creates space for the new implant. Your surgeon places a metal and plastic device into your hand to replace the damaged joint. This helps restore movement and reduce pain.

In some cases, your surgeon may use a silicone spacer instead of a rigid implant. This soft material sits between the bones to cushion the joint. If you have severe deformity, your surgeon might remove a small amount of bone from one side to straighten the finger. This is called an osteotomy. It helps the new joint sit in the correct position.

Your surgeon closes the cut with stitches or glue. A dressing is applied to protect the area. The operation is performed safely, even if you have complex trauma to the hand. Your surgeon will ensure the joint is stable before closing.

We understand this can feel like a big step. Our team is here to guide you through every part of the process. We aim to give you a functional hand that feels natural. You will have a clear plan for your recovery once the operation is complete.

After the operation

You will wake up in the recovery ward. We manage your pain with standard medication. Your hand will be wrapped in a clean dressing and supported in a soft sling or splint to protect the joint. Someone should stay with you for the first 24 hours to help you rest. Your team will tell you whether you go home the same day or stay one night in hospital. We advise gentle movement of your fingers as soon as it is comfortable to prevent stiffness. Avoid heavy lifting or gripping for now. Keep the dressing dry and clean. If you have questions about when you can drive, please refer to our guide on driving after upper-limb surgery.

Recovery

Your hand will feel stiff and swollen at first. This is normal. We manage this with elevation and gentle movement. Pain usually eases as the swelling settles. You will wear a protective dressing or splint to keep the joint safe while it heals.

Our hand therapist, Ruby Doolan at Extend Rehabilitation, guides your exercises. She directs your therapy and makes any splint you need. You will practice moving your fingers to regain flexibility. We focus on simple tasks you can do at home. Avoid heavy gripping until your surgeon clears you.

Your timeline may differ. Your surgeon and therapist will guide you based on how your hand responds. We aim for good pain relief and improved movement. You will know you are progressing when daily tasks become easier. Your surgeon will advise when it is safe to drive, based on your ability to control the vehicle safely.

What can go wrong

Most patients do well, but problems can occasionally happen. Your surgeon and the team monitor you closely to spot any issue early.

Joint Dislocation You might notice your finger suddenly shifts out of place. It may look crooked or feel unstable. You could experience a sharp pain or a clicking sensation when you try to move it. If this happens, do not try to force it back yourself. Contact our clinic immediately for advice on how to manage the joint safely until you can be seen.

Infection Deep joint infections are uncommon after this type of surgery. However, you should watch for signs of trouble. Look for redness that spreads away from your wound. You might feel warmth around the finger or notice swelling that does not improve. A deep, throbbing pain that does not ease with simple painkillers is also a warning sign. If you see these changes, call us right away. Early treatment is key to keeping the joint healthy.

Need for Further Surgery In some cases, the implant may wear out or fail, requiring another operation. This is more likely if you have inflammatory arthritis, such as rheumatoid arthritis. You might notice a return of pain or a loss of movement that you previously regained. If your symptoms worsen or do not improve as expected, bring this up at your next review. We will assess whether further intervention is needed to restore stability and function.

The complications table on this page lists typical rates if you want the specifics.

When to call us

Call us if you have fever, increasing wound redness or discharge, or sudden severe pain. Go to emergency for calf swelling or shortness of breath. Seek urgent care for loss of sensation or inability to move your hand. These signs need immediate assessment to protect your recovery and safety.

Advanced reading: the deeper science (optional)

This section goes further than you need for your own treatment decisions. Knuckle joint replacement is worth the extra reading because of a curiosity: the implant most used today is essentially the design introduced in the 1960s, and it has outlasted every material brought in to replace it. Understanding why explains what this operation is actually for.

Silicone has not been displaced

A 2026 review of metacarpophalangeal joint arthroplasty in rheumatoid arthritis concludes that the operation continues to play a central role in managing the rheumatoid hand, and that despite advances in implant technology, flexible silicone arthroplasty provides reliable functional and cosmetic improvement in appropriately selected patients [1].

Sixty years of materials science has produced metal-plastic and pyrocarbon alternatives, and the silicone spacer is still the reference standard. That is unusual in joint replacement, where hip and knee implants have been iterated continuously over the same period.

The reason is that this implant is not doing the job its name implies. It is not resurfacing a joint to restore a bearing. It is a flexible spacer that maintains a gap and acts as an internal splint while scar tissue forms around it into a new capsule. The result is delivered by the healing, not by the device — which is why a better bearing surface has never translated into a better outcome.

The honest summary of results

A review of implant arthroplasty across the finger and thumb joints puts it well: implant arthroplasty predictably produces pain relief and high satisfaction, but has historically suffered from high rates of complications, and while metal-plastic and pyrocarbon materials have evolved, survivorship and reoperation rates remain a concern [2].

Both halves matter. People are reliably pleased with these operations — pain goes, appearance improves, the hand works better for daily tasks — and the implants have a finite life with a real reoperation rate. Satisfaction and durability are different questions, and this operation scores much better on the first.

For osteoarthritis, the evidence is thin

Most of the literature concerns rheumatoid arthritis, because that is where the deformity being corrected is most dramatic. For osteoarthritis the picture is weaker: the available evidence consists of retrospective cohorts with small sample sizes and relatively short follow-up [3].

Notably, where authors express a preference for pyrocarbon over silicone in osteoarthritis, it is on the basis of potential for improved stability and alignment, with the data described as preliminary [3]. That is a reasonable position to hold, but it should be recognised as reasoning from mechanism rather than from demonstrated superiority.

Durability is becoming a bigger question

A concern raised nearly two decades ago has grown rather than resolved: implant durability matters more as life expectancy increases, and as these operations are done in younger, more active patients who will load them for longer [4]. An implant with acceptable ten-year performance is a different proposition at 75 than at 55.

Practically, this is a reason to be clear about what you want the operation to achieve. For pain relief, correction of deformity and improved function in a hand with modest mechanical demands, this is a well-supported operation with a long record. As a durable reconstruction for heavy use over decades, it is not.

Reviewed by Dr Kieran Hirpara · 13 August 2026.

Want the clinical detail? Read the clinician version.

Talk to your treating clinician for advice specific to you.

For an appointment with the CQ Hand + Upper Limb team, ask your GP about a referral or visit www.cqupperlimb.com.

References for the advanced reading
  1. Herren DB. Balancing metacarpophalangeal joint arthroplasty in rheumatoid arthritis. J Hand Surg Eur Vol. 2026;51(6):778-84.
  2. Srnec JJ, Wagner ER, Rizzo M. Implant arthroplasty for proximal interphalangeal, metacarpophalangeal, and trapeziometacarpal joint degeneration. J Hand Surg Am. 2017;42(10):817-25.
  3. Martin AS, Awan HM. Metacarpophalangeal arthroplasty for osteoarthritis. J Hand Surg Am. 2015;40(9):1871-2.
  4. Goldfarb CA, Dovan TT. Rheumatoid arthritis: silicone metacarpophalangeal joint arthroplasty indications, technique, and outcomes. Hand Clin. 2006;22(2):177-82.
Evidence & references

This is the clinical evidence summary written for health professionals. It is technical, and it lists the research this page was built from. You do not need to read it to understand your treatment or to make a decision about it.

Overview

  • Metacarpophalangeal joint arthroplasty is performed safely in the setting of acute complex open MCP joint trauma [1].
  • Revision MCP arthroplasty is a challenging procedure with one in five patients requiring a revision procedure at 5 years [2].
  • Revision MCP arthroplasty has a relatively high rate of postoperative dislocations [2].
  • Dorsal capsule interposition arthroplasty provides a viable surgical option for isolated degenerative or traumatic arthritis of the MCPJ at an average follow-up of 2 years [3].
  • Silastic interposition arthroplasty of the MCPJ is reliable in terms of pain relief and correction of deformity [4].
  • Patient satisfaction with silastic interposition arthroplasty of the MCPJ is high despite only modest improvements in the objective assessment of hand function [4].
  • Treatment of MCP joint arthroplasty dislocation with revision to silicone implant appears to hold the most promise in achieving a stable MCP joint after an acute prosthetic dislocation [5].
  • The nonconstrained implant design for the MCP joint can have good outcomes and excellent arc of motion in OA patients [7].
  • MCP joint arthroplasty is an effective treatment option from a patient-centered perspective, improving appearance, pain, and function [8].
  • Periprosthetic joint infection (PJI) is uncommon after MCP or PIP arthroplasties [9].
  • Patient expectations of MCP joint arthroplasty were uniformly high, with functional improvement being the greatest motivation for surgery [10].
  • Joint goal-setting is essential for understanding patients' unique reasons for undergoing MCP arthroplasty and facilitating realistic expectations [11].
  • Implant arthroplasty of the PIP, MCP, and TMC joints predictably produces pain relief and high satisfaction [20].
  • Implant arthroplasty of the PIP, MCP, and TMC joints has historically suffered from high rates of complications [20].
  • The evidence regarding MCP arthroplasty for OA consists of retrospective cohorts with small sample sizes and relatively short evaluations [22].

Anatomy & Pathophysiology

  • MCP joint arthroplasty was performed safely in the setting of acute complex open MCP joint trauma [1].
  • Increasing MCP joint flexion range was associated with increased fractures of silicone implants [6].
  • Nonconstrained implant designs for the MCP joint can provide good outcomes and excellent arc of motion in osteoarthritis patients [7].
  • Patients with greater hand function preoperatively may be at higher risk of revision surgery after silicone MCP arthroplasty [12].
  • Both NeuFlex and Swanson implant groups obtained satisfactory clinical improvement after MCP reconstruction in rheumatoid arthritis patients [14].
  • Swanson arthroplasty frequently results in a range of flexion of the MP joint of the little finger that may be insufficient for its principal functions [17].
  • A surgical strategy for severely collapsed zigzag thumb deformities involves gradual correction with external fixators following arthroplasty [18].
  • Not all MCP hyperextension deformities associated with trapeziometacarpal osteoarthritis require surgical interventions [19].
  • Secondary outcomes including key pinch strength, pain, the brief Michigan Hand Outcomes Questionnaire, and complications did not differ between groups at 2 years following correction of MCP hyperextension after trapeziometacarpal joint implant arthroplasty [21].
  • Thumb MCP joint capsulodesis performed concurrently with trapeziometacarpal arthroplasty can be a straightforward procedure that produces positive results [23].
  • Implant fractures following silicone MCP arthroplasty did not significantly affect upper limb function [27].
  • The hypothesis that ulnar fingers would have worse outcomes than radial fingers after silicone arthroplasty was not proven; sufficient correction of deformities in ulnar fingers is possible with adequate bone resection and realignment of the extensor mechanism [28].
  • Volar and proximal translation of the proximal phalanx was observed on 4-dimensional computed tomography after silicone implant arthroplasty in rheumatoid arthritis patients [29].
  • Implant-free anatomical reconstruction of thumb MCP joint chronic ulnar collateral ligament injuries achieved stable intra-osseous fixation and restored grip, pinch strength, and range of motion while avoiding drawbacks associated with implants [30].
  • Objective results after revision MCP surgery in rheumatoid patients following previous silicone arthroplasty were generally poor, with minimal improvement in ulnar drift, a high rate of implant fracture, and no change in arc of motion [33].
  • Maintaining finger position without recurrence of ulnar drift or extensor lag, and maintaining MCP arc of motion, corresponded with patient satisfaction after silicone MCP arthroplasty for rheumatoid arthritis [35].
  • Improvement in clinical assessments was comparable between bioreconstructive Poly-L/D-Lactide implants and Swanson prostheses, except for better maintenance of palmar alignment in the Swanson group [36].

Classification

  • MCP joint arthroplasty can be performed safely in the setting of acute complex open MCP joint trauma [1].
  • Revision MCP arthroplasty is a challenging procedure with a 20% (one in five) rate of requiring a revision procedure at 5 years and a relatively high rate of postoperative dislocations [2].
  • Dorsal capsule interposition arthroplasty is a viable surgical option for isolated degenerative or traumatic arthritis of the MCPJ [3].
  • Silastic interposition arthroplasty of the MCPJ is reliable for pain relief and correction of deformity, with high patient satisfaction despite modest improvements in objective hand function assessment [4].
  • Revision to a silicone implant is the treatment with the most promise for achieving a stable MCP joint after an acute prosthetic dislocation [5].
  • Increasing MCP joint flexion range is associated with increased fractures of silicone implants in patients with rheumatoid arthritis [6].
  • MCP joint arthroplasty is an effective treatment option for rheumatoid arthritis, improving appearance, pain, and function from a patient-centered perspective [8].
  • Patients with greater hand function preoperatively may be at higher risk of revision surgery after silicone MCP arthroplasty for inflammatory arthritis [12].
  • Both NeuFlex and Swanson implants provide satisfactory clinical improvement after MCP reconstruction in rheumatoid arthritis patients [14].
  • MCP joint arthroplasty continues to play a central role in the management of the rheumatoid hand [16].
  • Swanson silicone arthroplasty frequently results in insufficient flexion range of the little finger MP joint for its principal functions [17].
  • Not all MCP hyperextension deformities associated with trapeziometacarpal osteoarthritis require surgical intervention [19].

Clinical Presentation

  • Metacarpophalangeal joint arthroplasty is indicated for isolated degenerative or traumatic arthritis of the MCPJ [3].
  • Metacarpophalangeal joint arthroplasty is indicated for osteoarthritis of the MCP joint [7].
  • Metacarpophalangeal joint arthroplasty is indicated for noninflammatory arthritis of the MCP joints [13].
  • Metacarpophalangeal joint arthroplasty is indicated for nonrheumatic metacarpophalangeal joint arthritis [24].
  • Metacarpophalangeal joint arthroplasty plays a central role in the management of the rheumatoid hand [16].
  • Metacarpophalangeal joint arthroplasty is an effective treatment option for rheumatoid arthritis, improving appearance, pain, and function [8].
  • Patient expectations of MCP joint arthroplasty are uniformly high [10].
  • Functional improvement is the greatest motivation for MCP joint arthroplasty surgery [10].
  • Hand appearance is a patient motivation for surgery and a determinant of satisfaction with MCP joint arthroplasty for rheumatoid arthritis [10].
  • Implant arthroplasty of the MCP joints predictably produces pain relief and high satisfaction [20].
  • Silastic interposition arthroplasty of the MCPJ results in high patient satisfaction despite only modest improvements in the objective assessment of hand function [4].
  • Silicone arthroplasty for nonrheumatic arthritis results in excellent pain relief and excellent patient satisfaction [24].
  • Pain ratings significantly improve following surface replacement arthroplasty in MCP joints affected by noninflammatory arthritis [13].
  • The arc of motion significantly improves following surface replacement arthroplasty in MCP joints affected by noninflammatory arthritis [13].
  • Silicone arthroplasty for nonrheumatic arthritis results in improved range of motion and DASH score [24].
  • Swanson silicone arthroplasty frequently results in a range of flexion of the MP joint of the little finger that may be insufficient for its principal functions [17].
  • Increasing MCP joint flexion range is associated with increased fractures of silicone implants [6].
  • One in five patients requires a revision procedure at 5 years following revision MCP arthroplasty [2].
  • Squeaking in pyrolytic carbon MCP joint replacement can be associated with pain and swelling [34].

Investigations

  • Patient satisfaction is high following silastic interposition arthroplasty of the MCPJ despite only modest improvements in the objective assessment of hand function [4].
  • Increasing MCP joint flexion range was associated with increased fractures of silicone implants in patients with rheumatoid arthritis [6].
  • The nonconstrained implant design for the MCP joint can have good outcomes and excellent arc of motion in osteoarthritis patients [7].
  • MCP joint arthroplasty is an effective treatment option from a patient-centered perspective, improving appearance, pain, and function in rheumatoid arthritis [8].
  • Patients with greater hand function preoperatively may be at higher risk of revision surgery after silicone metacarpophalangeal joint arthroplasty in inflammatory arthritis [12].
  • Pain ratings and MCP arc of motion significantly improved following surface replacement arthroplasty in metacarpophalangeal joints affected by noninflammatory arthritis [13].
  • Both NeuFlex and Swanson metacarpophalangeal implants obtained satisfactory clinical improvement after MCP reconstruction of the hand in rheumatoid arthritis [14].
  • The articulated spacer technique can be considered an option to maintain motion while treating infected MCPJ arthroplasties, avoiding co-morbidity resulting from immobilisation [15].
  • Metacarpophalangeal joint arthroplasty continues to play a central role in the management of the rheumatoid hand [16].
  • The study proposes a surgical strategy for severely collapsed zigzag thumb deformities using gradual correction with external fixators [18].
  • Not all MCP hyperextension deformities will require surgical interventions according to known algorithms [19].
  • Secondary outcomes including key pinch strength, pain, the brief Michigan Hand Outcomes Questionnaire and complications did not differ between groups at 2 years in the correction of MCP hyperextension following trapeziometacarpal joint implant arthroplasty [21].
  • The evidence regarding MCP arthroplasty for osteoarthritis consists of retrospective cohorts with small sample sizes and relatively short evaluations [22].

Treatment

  • Metacarpophalangeal joint arthroplasty can be performed safely in the setting of acute complex open MCP joint trauma [1].
  • Secondary outcomes including key pinch strength, pain, the brief Michigan Hand Outcomes Questionnaire and complications did not differ between groups at 2 years following correction of metacarpophalangeal joint hyperextension following trapeziometacarpal joint implant arthroplasty [21].
  • Silicone arthroplasty for nonrheumatic metacarpophalangeal joint arthritis showed improved range of motion and DASH score, excellent pain relief, and excellent patient satisfaction [24].
  • Intraoperative fractures occurred in 3% of MCP joint arthroplasties and were associated with pyrocarbon implants, cementless fixation, and diabetes mellitus [25].
  • Good pain relief, a functional range of motion, and high satisfaction were seen in the majority of patients following pyrocarbon metacarpophalangeal joint arthroplasty in noninflammatory arthritis at minimum 5-year follow-up [26].
  • The indications for and long-term expectations of silicone metacarpophalangeal arthroplasty must be carefully examined in light of the improvements in the medical management of rheumatoid disease [31].
  • A long stem ulnar prosthesis, with or without radial osteotomy, is advocated as a salvage procedure for failed Sauve-Kapandji procedures resulting in fracture of the proximal phalanx pyrocarbon implant [32].

Complications

  • The treatment of acute MCP joint arthroplasty dislocation with revision to silicone implant appears to hold the most promise in achieving a stable MCP joint after an acute prosthetic dislocation [5].
  • PJI is uncommon after MCP or PIP arthroplasties [9].
  • Patients with greater hand function preoperatively may be at higher risk of revision surgery after silicone MCP arthroplasty in patients with inflammatory arthritis [12].
  • Implant arthroplasty of the MCP joints has historically suffered from high rates of complications [20].
  • Complication and overall reoperation rates were high for pyrocarbon arthroplasty in MCP joints affected by rheumatoid arthritis [37].
  • One in 10 patients with pyrocarbon arthroplasty for rheumatoid arthritis undergo revision within 5 years postoperatively [37].
  • Metacarpophalangeal arthroplasty using a pyrocarbon implant for osteoarthritis demonstrates a 7% revision rate at 5 years after surgery [38].

Recovery

  • Revision MCP arthroplasty is a challenging procedure [2].
  • One in five patients require a revision procedure at 5 years [2].
  • There is a relatively high rate of postoperative dislocations following revision MCP arthroplasty [2].
  • Silastic interposition arthroplasty of the MCPJ is reliable in terms of pain relief [4].
  • Silastic interposition arthroplasty of the MCPJ is reliable in terms of correction of deformity [4].
  • Patient satisfaction is high following silastic interposition arthroplasty of the MCPJ [4].
  • There are only modest improvements in the objective assessment of hand function following silastic interposition arthroplasty of the MCPJ [4].
  • MCP joint arthroplasty is an effective treatment option from a patient-centered perspective for rheumatoid arthritis [8].
  • MCP joint arthroplasty improves appearance for patients with rheumatoid arthritis [8].
  • MCP joint arthroplasty improves pain for patients with rheumatoid arthritis [8].
  • MCP joint arthroplasty improves function for patients with rheumatoid arthritis [8].
  • Patient expectations of MCP joint arthroplasty were uniformly high [10].
  • Functional improvement was the greatest motivation for surgery in patients undergoing MCP joint arthroplasty [10].
  • Joint goal-setting is essential for understanding patients' unique reasons for undergoing MCP arthroplasty [11].
  • Joint goal-setting facilitates realistic expectations for patients undergoing MCP arthroplasty [11].
  • Pain ratings significantly improved following surface replacement arthroplasty in metacarpophalangeal joints affected by noninflammatory arthritis [13].
  • MCP arc of motion significantly improved following surface replacement arthroplasty in metacarpophalangeal joints affected by noninflammatory arthritis [13].
  • HAPY spherical pyrocarbon interposition arthroplasty for the metacarpophalangeal joint demonstrates satisfactory short- to mid-term outcomes [40].
  • HAPY spherical pyrocarbon interposition arthroplasty for the metacarpophalangeal joint results in considerable improvements in pain relief [40].
  • HAPY spherical pyrocarbon interposition arthroplasty for the metacarpophalangeal joint results in considerable improvements in joint mobility [40].

Key Evidence

  • [L4] MCP joint arthroplasty was performed safely in the setting of acute complex open MCP joint trauma. [1] (10.1016/j.jhsa.2015.09.012)
  • [L4] Revision MCP arthroplasty is a challenging procedure with one in five patients requiring a revision procedure at 5 years and a relatively high rate of postoperative dislocations. [2] (10.5435/jaaos-d-17-00042)
  • [L4] This technique of dorsal capsule interposition arthroplasty provides a viable surgical option for isolated degenerative or traumatic arthritis of the MCPJ at an average follow-up of 2 years. [3] (10.1177/1558944720911215)
  • [L4] Silastic interposition arthroplasty of the MCPJ is reliable in terms of pain relief and correction of deformity, and patient satisfaction is high despite only modest improvements in the objective assessment of hand function. [4] (10.1054/jhsb.2000.0402)
  • [L4] The treatment of MCP joint arthroplasty dislocation with revision to silicone implant appears to hold the most promise in achieving a stable MCP joint after an acute prosthetic dislocation. [5] (10.1016/j.jhsa.2017.10.001)
  • [L4] Increasing MCP joint flexion range was associated with increased fractures of the implants. [6] (10.1016/j.jhsa.2020.09.002)
  • [L5] The nonconstrained implant design for the MCP joint can have good outcomes and excellent arc of motion in OA patients. [7] (10.1016/j.jhsa.2012.11.025)
  • [L4] MCP joint arthroplasty is an effective treatment option from a patient-centered perspective, improving appearance, pain, and function. [8] (10.1016/j.hcl.2006.02.001)
  • [L4] PJI is uncommon after MCP or PIP arthroplasties. [9] (10.1016/j.jhsa.2024.12.008)
  • [L1] Patient expectations of MCP joint arthroplasty were uniformly high, with functional improvement being the greatest motivation for surgery. [10] (10.1016/j.jhsa.2011.02.002)
  • [L4] Joint goal-setting is essential for understanding patients' unique reasons for undergoing MCP arthroplasty and facilitating realistic expectations. [11] (10.1002/msc.1061)
  • [L3] Patients with greater hand function preoperatively may be at higher risk of revision surgery. [12] (10.1177/1558944719831236)
  • [L4] Pain ratings and MCP arc of motion significantly improved following arthroplasty. [13] (10.1177/15589447211028917)
  • [L1] Both implant groups obtained satisfactory clinical improvement after MCP reconstruction of the hand. [14] (10.1016/j.jhsa.2009.09.020)
  • [L5] The articulated spacer technique can be considered an option to maintain motion while treating infected MCPJ arthroplasties, avoiding co-morbidity resulting from immobilisation. [15] (10.1177/17531934251323067)
  • [L5] Metacarpophalangeal joint arthroplasty continues to play a central role in the management of the rheumatoid hand. [16] (10.1177/17531934261430139)
  • [L4] Our experience with this cohort, a review of published literature, and a survey of international experts suggest that Swanson arthroplasty frequently results in a range of flexion of the MP joint of the little finger that may be insufficient for its principal functions. [17] (10.1007/s11552-007-9051-5)
  • [Paper] The study proposes a surgical strategy for severely collapsed zigzag thumb deformities using gradual correction with external fixators. [18] (10.1007/s12593-015-0178-2)
  • [L4] Not all MCP hyperextension deformities will require surgical interventions according to known algorithms. [19] (10.1007/s00402-021-03838-8)
  • [L4] Implant arthroplasty of the PIP, MCP, and TMC joints predictably produces pain relief and high satisfaction but has historically suffered from high rates of complications. [20] (10.1016/j.jhsa.2017.07.030)
  • [L3] Secondary outcomes including key pinch strength, pain, the brief Michigan Hand Outcomes Questionnaire and complications did not differ between groups at 2 years. [21] (10.1177/17531934251330975)
  • [L4] The evidence regarding MCP arthroplasty for OA consists of retrospective cohorts with small sample sizes and relatively short evaluations. [22] (10.1016/j.jhsa.2015.05.019)
  • [L4] Thumb MCP joint capsulodesis performed concurrently with trapeziometacarpal arthroplasty can be a straightforward procedure that produces positive results. [23] (10.1016/j.jhsa.2014.07.045)
  • [L3] This study showed improved range of motion and DASH score, excellent pain relief, and excellent patient satisfaction in patients undergoing MCP arthroplasty for nonrheumatic arthritis. [24] (10.1016/j.jhsa.2013.09.016)
  • [L3] Intraoperative fractures occurred in 3% of MCP joint arthroplasties and were associated with pyrocarbon implants, cementless fixation, and diabetes mellitus. [25] (10.1016/j.jhsa.2014.12.038)
  • [L4] Good pain relief, a functional range of motion, and high satisfaction were seen in the majority of patients. [26] (10.1016/j.jhsa.2015.06.104)
  • [L4] However, implant fractures did not significantly affect upper limb function. [27] (10.1016/j.jhsa.2024.01.009)
  • [L2] The hypothesis that ulnar fingers would have worse outcomes than radial fingers was not proven; sufficient correction of deformities in ulnar fingers is possible if adequate bone resection and realigning of the extensor mechanism are carefully performed. [28] (10.1016/j.jhsa.2009.06.029)
  • [L4] Volar and proximal translation of the proximal phalange was observed on 4-dimensional computed tomography. [29] (10.1016/j.jhsa.2021.10.001)
  • [L4] The surgical procedure achieved stable intra-osseous fixation and restored grip, pinch strength, and range of motion while avoiding drawbacks associated with implants. [30] (10.1177/17531934231182895)
  • [L4] Given these findings, the indications for and long-term expectations of silicone metacarpophalangeal arthroplasty must be carefully examined in light of the improvements in the medical management of rheumatoid disease. [31] (10.2106/00004623-200310000-00001)
  • [L4] The authors advocate the use of a long stem ulnar prosthesis, with or without radial osteotomy, as a salvage procedure for failed Sauve-Kapandji procedures. [32] (10.1177/1753193410384891)
  • [L4] Objective results, however, were generally poor, with minimal improvement in ulnar drift, a high rate of implant fracture, and no change in arc of motion. [33] (10.1016/j.jhsa.2007.07.026)
  • [L5] If squeaking is associated with pain and swelling, revision MCP joint arthroplasty is recommended to identify and correct the underlying cause, such as implant subsidence or an incongruous joint. [34] (10.1016/j.jhsg.2022.10.002)
  • [L2] However, maintaining finger position, without recurrence of ulnar drift or extensor lag, and MCP arc of motion corresponded with patient satisfaction in the postoperative period. [35] (10.1016/j.jhsa.2011.09.042)
  • [L1] Improvement in clinical assessments was comparable in both groups, except for better maintenance of palmar alignment in the Swanson group. [36] (10.1177/1753193410375777)
  • [L4] Complication and overall reoperation rates were high, while 1 in 10 undergo revision within 5 years postoperatively. [37] (10.1177/15589447211063577)
  • [L4] Metacarpophalangeal arthroplasty using a pyrocarbon implant for osteoarthritis demonstrates a 7% revision rate at 5 years after surgery. [38] (10.1016/j.jhsa.2022.08.013)
  • [L4] The HAPY spherical pyrocarbon interposition arthroplasty for the metacarpophalangeal joint demonstrates satisfactory short- to mid-term outcomes, with considerable improvements in pain relief and joint mobility. [40] (10.1016/j.jhsg.2025.100804)

References

[1] Metacarpophalangeal Joint Arthroplasty in the Setting of Trauma. The Journal of Hand Surgery. 2015. DOI: 10.1016/j.jhsa.2015.09.012

[2] Revision Metacarpophalangeal Arthroplasty: A Longitudinal Study of 128 Cases. Journal of the American Academy of Orthopaedic Surgeons. 2019. DOI: 10.5435/jaaos-d-17-00042

[3] Dorsal Capsule Interpositional Arthroplasty of the Metacarpophalangeal Joint. HAND. 2020. DOI: 10.1177/1558944720911215

[4] Outcome Measures Following Metacarpophalangeal Joint Replacement. Journal of Hand Surgery. 2000. DOI: 10.1054/jhsb.2000.0402

[5] Outcomes Following Acute Metacarpophalangeal Joint Arthroplasty Dislocation: An Analysis of 37 Cases. The Journal of Hand Surgery. 2018. DOI: 10.1016/j.jhsa.2017.10.001

[6] Risk Factors Contributing to Early Implant Fracture in Silicone Metacarpophalangeal Joint Arthroplasty for Patients With Rheumatoid Arthritis. The Journal of Hand Surgery. 2021. DOI: 10.1016/j.jhsa.2020.09.002

[7] Clinical and Radiographic Outcomes of Metacarpophalangeal Joint Pyrolytic Carbon Arthroplasty for Osteoarthritis. The Journal of Hand Surgery. 2013. DOI: 10.1016/j.jhsa.2012.11.025

[8] Rheumatoid Arthritis: Silicone Metacarpophalangeal Joint Arthroplasty Indications, Technique, and Outcomes. Hand Clinics. 2006. DOI: 10.1016/j.hcl.2006.02.001

[9] Incidence and Presentation of Periprosthetic Joint Infection After Primary Metacarpophalangeal and Proximal Interphalangeal Arthroplasty. The Journal of Hand Surgery. 2025. DOI: 10.1016/j.jhsa.2024.12.008

[10] Hand Appearance as a Patient Motivation for Surgery and a Determinant of Satisfaction with Metacarpophalangeal Joint Arthroplasty for Rheumatoid Arthritis. The Journal of Hand Surgery. 2011. DOI: 10.1016/j.jhsa.2011.02.002

[11] Patients' Expectations, Experiences and the Determinants of Satisfaction related to Metacarpophalangeal Arthroplasty. Musculoskeletal Care. 2013. DOI: 10.1002/msc.1061

[12] Factors Associated With Reoperation After Silicone Metacarpophalangeal Joint Arthroplasty in Patients With Inflammatory Arthritis. HAND. 2019. DOI: 10.1177/1558944719831236

[13] Outcomes of Surface Replacement Arthroplasty in Metacarpophalangeal Joints Affected by Noninflammatory Arthritis. HAND. 2021. DOI: 10.1177/15589447211028917

[14] NeuFlex and Swanson Metacarpophalangeal Implants for Rheumatoid Arthritis: Prospective Randomized, Controlled Clinical Trial. The Journal of Hand Surgery. 2010. DOI: 10.1016/j.jhsa.2009.09.020

[15] Management of an infected metacarpophalangeal joint replacement with a temporary articulated cement spacer. Journal of Hand Surgery (European Volume). 2025. DOI: 10.1177/17531934251323067

[16] Balancing metacarpophalangeal joint arthroplasty in rheumatoid arthritis. Journal of Hand Surgery (European Volume). 2026. DOI: 10.1177/17531934261430139

[17] Insufficient Flexion of the Metacarpophalangeal Joint of the Little Finger Following Swanson Silicone Arthroplasty for Rheumatoid Arthritis. HAND. 2007. DOI: 10.1007/s11552-007-9051-5

[18] Correction of a Hyperextension Deformity at the Metacarpophalangeal Joint by Arthroplasty for Osteoarthritis of the Thumb Carpometacarpal Joint Followed by External Fixator: A Case Series. Journal of Hand and Microsurgery. 2015. DOI: 10.1007/s12593-015-0178-2

[19] Does trapeziectomy with ligament reconstruction and tendon interposition arthroplasty correct the metacarpophalangeal joint hyperextension associated with trapeziometacarpal osteoarthritis?. Archives of Orthopaedic and Trauma Surgery. 2021. DOI: 10.1007/s00402-021-03838-8

[20] Implant Arthroplasty for Proximal Interphalangeal, Metacarpophalangeal, and Trapeziometacarpal Joint Degeneration. The Journal of Hand Surgery. 2017. DOI: 10.1016/j.jhsa.2017.07.030

[21] Correction of metacarpophalangeal joint hyperextension following trapeziometacarpal joint implant arthroplasty: a case–control study. Journal of Hand Surgery (European Volume). 2025. DOI: 10.1177/17531934251330975

[22] Metacarpophalangeal Arthroplasty for Osteoarthritis. The Journal of Hand Surgery. 2015. DOI: 10.1016/j.jhsa.2015.05.019

[23] Volar Capsulodesis of the Thumb Metacarpophalangeal Joint at the Time of Basal Joint Arthroplasty: A Surgical Technique Using Suture Anchors. The Journal of Hand Surgery. 2014. DOI: 10.1016/j.jhsa.2014.07.045

[24] Silicone Arthroplasty for Nonrheumatic Metacarpophalangeal Joint Arthritis. The Journal of Hand Surgery. 2013. DOI: 10.1016/j.jhsa.2013.09.016

[25] Intraoperative Periprosthetic Fractures Associated With Metacarpophalangeal Joint Arthroplasty. The Journal of Hand Surgery. 2015. DOI: 10.1016/j.jhsa.2014.12.038

[26] Pyrocarbon Metacarpophalangeal Joint Arthroplasty in Noninflammatory Arthritis: Minimum 5-Year Follow-Up. The Journal of Hand Surgery. 2015. DOI: 10.1016/j.jhsa.2015.06.104

[27] Long-Term Implant Fracture Rates Following Silicone Metacarpophalangeal Joint Arthroplasty in Rheumatoid Arthritis. The Journal of Hand Surgery. 2024. DOI: 10.1016/j.jhsa.2024.01.009

[28] Outcomes of Silicone Arthroplasty for Rheumatoid Metacarpophalangeal Joints Stratified by Fingers. The Journal of Hand Surgery. 2009. DOI: 10.1016/j.jhsa.2009.06.029

[29] In Vivo Metacarpophalangeal Joint Kinematics After Silicone Implant Arthroplasty in Patients With Rheumatoid Arthritis. The Journal of Hand Surgery. 2023. DOI: 10.1016/j.jhsa.2021.10.001

[30] Implant-free anatomical reconstruction of thumb metacarpophalangeal joint chronic ulnar collateral ligament injuries. Journal of Hand Surgery (European Volume). 2023. DOI: 10.1177/17531934231182895

[31] METACARPOPHALANGEAL JOINT ARTHROPLASTY IN RHEUMATOID ARTHRITIS. The Journal of Bone and Joint Surgery-American Volume. 2003. DOI: 10.2106/00004623-200310000-00001

[32] Fracture of the proximal phalanx pyrocarbon implant after metacarpophalangeal arthroplasty. Journal of Hand Surgery (European Volume). 2011. DOI: 10.1177/1753193410384891

[33] Results of Revision Metacarpophalangeal Joint Surgery in Rheumatoid Patients Following Previous Silicone Arthroplasty. The Journal of Hand Surgery. 2007. DOI: 10.1016/j.jhsa.2007.07.026

[34] A Painful, Squeaking Pyrolytic Carbon Metacarpophalangeal Joint Replacement. Journal of Hand Surgery Global Online. 2023. DOI: 10.1016/j.jhsg.2022.10.002

[35] Objective Functional Outcomes and Patient Satisfaction After Silicone Metacarpophalangeal Arthroplasty for Rheumatoid Arthritis. The Journal of Hand Surgery. 2012. DOI: 10.1016/j.jhsa.2011.09.042

[36] Bioreconstructive Poly-L/D-Lactide Implant Compared With Swanson Prosthesis in Metacarpophalangeal Joint Arthroplasty in Rheumatoid Patients: a Randomized Clinical Trial. Journal of Hand Surgery (European Volume). 2010. DOI: 10.1177/1753193410375777

[37] Outcomes of Pyrocarbon Arthroplasty in Metacarpophalangeal Joints Affected by Rheumatoid Arthritis. HAND. 2022. DOI: 10.1177/15589447211063577

[38] Metacarpophalangeal Joint Pyrocarbon Arthroplasty for Osteoarthritis: An Analysis of 44 Arthroplasties. The Journal of Hand Surgery. 2024. DOI: 10.1016/j.jhsa.2022.08.013

[40] Functional Outcomes of Spherical Pyrocarbon HAPY Metacarpophalangeal Interposition Arthroplasty for Long Fingers: A Retrospective Study of 16 Cases. Journal of Hand Surgery Global Online. 2025. DOI: 10.1016/j.jhsg.2025.100804

Creative Commons BY-NC 4.0

CC Creative Commons licence
BY Attribution — you must credit the source
NC NonCommercial — not for commercial use

Attribution-NonCommercial 4.0 International

Creative Commons Corporation ("Creative Commons") is not a law firm and does not provide legal services or legal advice. Distribution of Creative Commons public licenses does not create a lawyer-client or other relationship. Creative Commons makes its licenses and related information available on an "as-is" basis. Creative Commons gives no warranties regarding its licenses, any material licensed under their terms and conditions, or any related information. Creative Commons disclaims all liability for damages resulting from their use to the fullest extent possible.

Using Creative Commons Public Licenses

Creative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders may use to share original works of authorship and other material subject to copyright and certain other rights specified in the public license below. The following considerations are for informational purposes only, are not exhaustive, and do not form part of our licenses.

Considerations for licensors: Our public licenses are intended for use by those authorized to give the public permission to use material in ways otherwise restricted by copyright and certain other rights. Our licenses are irrevocable. Licensors should read and understand the terms and conditions of the license they choose before applying it. Licensors should also secure all rights necessary before applying our licenses so that the public can reuse the material as expected. Licensors should clearly mark any material not subject to the license. This includes other CC- licensed material, or material used under an exception or limitation to copyright. More considerations for licensors: wiki.creativecommons.org/Considerations_for_licensors

Considerations for the public: By using one of our public licenses, a licensor grants the public permission to use the licensed material under specified terms and conditions. If the licensor's permission is not necessary for any reason--for example, because of any applicable exception or limitation to copyright--then that use is not regulated by the license. Our licenses grant only permissions under copyright and certain other rights that a licensor has authority to grant. Use of the licensed material may still be restricted for other reasons, including because others have copyright or other rights in the material. A licensor may make special requests, such as asking that all changes be marked or described. Although not required by our licenses, you are encouraged to respect those requests where reasonable. More considerations for the public: wiki.creativecommons.org/Considerations_for_licensees

Creative Commons Attribution-NonCommercial 4.0 International Public License

By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NonCommercial 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.

Section 1 -- Definitions.

a. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.

b. Adapter's License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.

c. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.

d. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.

e. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.

f. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.

g. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.

h. Licensor means the individual(s) or entity(ies) granting rights under this Public License.

i. NonCommercial means not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is NonCommercial provided there is no payment of monetary compensation in connection with the exchange.

j. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.

k. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.

l. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.

Section 2 -- Scope.

a. License grant.

1. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:

a. reproduce and Share the Licensed Material, in whole or in part, for NonCommercial purposes only; and

b. produce, reproduce, and Share Adapted Material for NonCommercial purposes only.

2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.

3. Term. The term of this Public License is specified in Section 6(a).

4. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a) (4) never produces Adapted Material.

5. Downstream recipients.

a. Offer from the Licensor -- Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.

b. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.

6. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).

b. Other rights.

1. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.

2. Patent and trademark rights are not licensed under this Public License.

3. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties, including when the Licensed Material is used other than for NonCommercial purposes.

Section 3 -- License Conditions.

Your exercise of the Licensed Rights is expressly made subject to the following conditions.

a. Attribution.

1. If You Share the Licensed Material (including in modified form), You must:

a. retain the following if it is supplied by the Licensor with the Licensed Material:

i. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);

ii. a copyright notice;

iii. a notice that refers to this Public License;

iv. a notice that refers to the disclaimer of warranties;

v. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;

b. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and

c. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.

2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.

3. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.

4. If You Share Adapted Material You produce, the Adapter's License You apply must not prevent recipients of the Adapted Material from complying with this Public License.

Section 4 -- Sui Generis Database Rights.

Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:

a. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database for NonCommercial purposes only;

b. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and

c. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.

For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.

Section 5 -- Disclaimer of Warranties and Limitation of Liability.

a. UNLESS OTHERWISE SEPARATELY UNDERTAKEN BY THE LICENSOR, TO THE EXTENT POSSIBLE, THE LICENSOR OFFERS THE LICENSED MATERIAL AS-IS AND AS-AVAILABLE, AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED MATERIAL, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHER. THIS INCLUDES, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OR ABSENCE OF ERRORS, WHETHER OR NOT KNOWN OR DISCOVERABLE. WHERE DISCLAIMERS OF WARRANTIES ARE NOT ALLOWED IN FULL OR IN PART, THIS DISCLAIMER MAY NOT APPLY TO YOU.

b. TO THE EXTENT POSSIBLE, IN NO EVENT WILL THE LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE) OR OTHERWISE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES, OR DAMAGES ARISING OUT OF THIS PUBLIC LICENSE OR USE OF THE LICENSED MATERIAL, EVEN IF THE LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES, COSTS, EXPENSES, OR DAMAGES. WHERE A LIMITATION OF LIABILITY IS NOT ALLOWED IN FULL OR IN PART, THIS LIMITATION MAY NOT APPLY TO YOU.

c. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.

Section 6 -- Term and Termination.

a. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.

b. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:

1. automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or

2. upon express reinstatement by the Licensor.

For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.

c. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.

d. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.

Section 7 -- Other Terms and Conditions.

a. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.

b. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.

Section 8 -- Interpretation.

a. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.

b. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.

c. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.

d. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.

Creative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the “Licensor.” The text of the Creative Commons public licenses is dedicated to the public domain under the CC0 Public Domain Dedication. Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at creativecommons.org/policies, Creative Commons does not authorize the use of the trademark "Creative Commons" or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.

Creative Commons may be contacted at creativecommons.org.